Exhibit 10.7 OPTION AGREEMENT Option agreement dated as of March 5, 1999 between B. TWELVE, INC., a corporation existing under the laws of the State of Florida (the "Corporation") and DR. URI SAGMAN, an individual residing in the Province of Ontario...Option Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations • Florida
Exhibit 10.14 TERMINATION AGREEMENT This Termination Agreement (the "Agreement") is made and entered into this 28th day of February, 2002, by and between The University of Texas M.D. Anderson Cancer Center ("UTMDACC"), a component institution of The...Termination Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations • Texas
EXHIBIT 10.13 AMENDMENT No. 1 TO RESEARCHResearch Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations
AMENDED AND RESTATED UNANIMOUS SHAREHOLDERS' AGREEMENT Amended and restated unanimous shareholders' agreement dated January 15, 2001 among B. TWELVE, INC. (herein "B 12" or the "Corporation"), DR. URI SAGMAN ("Sagman"), CREDIFINANCE CAPITAL CORP....Shareholder Agreements • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations • Florida
AND ---Collaborative Research Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations
Exhibit 10.10 RESEARCH COLLABORATION AGREEMENT BETWEEN THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AND B TWELVE LTD. AGREEMENT made this 19 day of August 1999 by and between THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, a...Research Collaboration Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations • New York
1. PROTOCOLSponsored Laboratory Study Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations • Texas
EXTENSION/MODIFICATION RESEARCH COLLABORATION AGREEMENT BETWEEN THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AND B TWELVE LTDResearch Collaboration Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations
